Gilboa Therapeutics

Gilboa Therapeutics develops a novel cell therapy for solid cancers. Founded in 2021, Gilboa Therapeutics is backed by investors that include NFX and is headquartered in Azor.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.